CME Outfitters

03/20/2026

Download resources and collect credit: https://cmeo.me/SN-270-encore

03/20/2026

Interpreting liver diagnostics doesn’t have to be complicated.

This concise CME Snack walks you through how and when to use non-invasive tools like FibroScan, ELF scoring, and MRE to stage and monitor MASLD/MASH.
Gain insights from experts Dr. Monica Tincopa (UCSD Health) and Dr. Amreen Dinani (Duke University School of Medicine).

🎓 Earn 0.5 CME/CE credits
👉 https://cmeo.me/SN-284

Building on the patient case introduced in Part 1, this CME Outfitters Snack takes learners through the next steps in evaluating Mr. B, a patient with relatively normal liver function tests but an indeterminate Fibrosis-4 (FIB-4)...

03/20/2026

🙌 Thank you for participating in our activity:
Personalizing Therapy in a Complex MuSK+ Patient

Help spread the learning—share the on-demand archive with your colleagues today! 👥📣
👉 View the activity: https://cmeo.me/BC-143

💡 Put information into action

🔹 Document key clinical markers during gMG visits—AChR/MuSK status, MG-ADL (± QMG), steroid/IST use, and recent rescue therapies—to identify patients who may benefit from treatment optimization

🔹 Initiate shared decision-making conversations to align treatment strategies, administration routes (IV vs SC), and monitoring plans with patient priorities

🔹 Reassess MG-ADL (± QMG) within 6 weeks of therapy changes to guide treatment continuation and dosing decisions

🔹 For stable patients on prednisone, implement and track a steroid taper plan while monitoring steroid burden and related health markers

🔹 Provide infection-risk counseling, monitor adverse events, and verify appropriate administration and retreatment intervals for ongoing care

Strengthening individualized care strategies can help improve outcomes for patients living with gMG.

Generalized myasthenia gravis (gMG) disrupts neuromuscular transmission, creating unpredictable symptom flare-ups and placing a significant burden on patients with this rare condition. Most commonly associated with antibodies targeting the acetylcholine receptor (AChR), and less commonly with...

03/20/2026

HIV prevention starts with routine, status-neutral screening and open conversations about prevention strategies like PrEP.

Learn practical approaches to overcoming barriers and improving equitable HIV prevention in this expert-led CME Snack.

👉 View the activity: https://cmeo.me/SN-305

Despite significant strides in HIV prevention, global incidence rates remain high, especially among underserved populations, due in part to persistent barriers in routine screening and access to pre-exposure prophylaxis (PrEP). Many healthcare professionals across the globe,...

03/20/2026

👨‍👩‍👧‍👦 Engaging Family Systems in Pediatric Care

Effective child and adolescent care goes beyond the patient—it requires understanding family roles, decision-makers, and preferred communication styles.

This on-demand CME Snack equips care teams with tools to develop care plans that reflect family priorities while addressing social drivers of health.

Learn more:
🔗 https://cmeo.me/SN-291

Culturally respectful care starts at the very beginning of life, shaped by the rich lived experiences, traditions, and values that influence how children and families interact with the healthcare system. Every family brings unique circumstances, and...

03/19/2026

📣 CME Outfitters Featured by the CME Coalition

We’re proud to be recognized in the CME Coalition’s Monthly Report for our work advancing health access and equity through accredited education.

The feature highlights more than 150 activities designed to address real-world barriers to care—from disparities and bias mitigation to maternal health, pediatric care, and food as medicine—driving measurable improvements in clinician performance and patient outcomes.

👉 Read the full blog here: https://cmeo.me/CME-Coalition-Blog

CME Outfitters is proud to be featured by the CME Coalition in its Monthly Report, an e-newsletter reaching leaders across the continuing medical education community. The CME Coalition spotlights member organizations whose work demonstrates the impact...

03/19/2026

🏥 From primary care to addiction medicine and sexual health clinics, every setting plays a role in hepatitis elimination.

Learn strategies you can apply across diverse practice environments.
🔗 https://cmeo.me/SN-277

The final program in the Linking Knowledge to Action: Empowering HCPs in Screening and Treatment of Patients Across the Viral Hepatitis Spectrum series focuses on practical and equitable approaches to meeting the World Health Organization’s 2030...

03/19/2026

Lennox-Gastaut syndrome doesn’t just impact children—it’s a lifelong condition requiring evolving, multidisciplinary care.

In this expert-led CME, discover:
🔎 Early & late-onset diagnostic strategies
🧠 Lifespan management techniques
💡 How to support patients & caregivers across decades

Watch now: https://cmeo.me/MMV146AANN

Lennox-Gastaut syndrome (LGS) remains a challenging condition to understand, diagnose, and manage. Neuroscience/neurology clinicians, including nurses and nurse practitioners (NPs), encounter significant challenges in the management of patients with LGS, due to the severe symptoms and...

03/19/2026

🧠 CIDP Masterclass – Session 2

Accurate diagnosis of CIDP can be challenging due to variable presentations and overlap with other neuropathies. Join us for Making an Accurate Diagnosis: Clinical Presentation and Diagnostic Criteria on April 14, 2026 | 8–9 PM EDT.

This Project ECHO® initiative is a collaboration between CME Outfitters and Boston University Chobanian & Avedisian School of Medicine.

📌 Built around real, de-identified cases submitted by participants.
💰 Case presenters receive an honorarium.
🔗 https://cmeo.me/ECH-002

Register and submit a case

Tuesday, April 14, 2026 | 8:00–9:00 PM ET Activity Description Accurate diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) remains a significant clinical challenge due to its variable presentations and overlap with other neuropathies, often leading to delayed...

03/19/2026

Even with the FDA’s Mycophenolate REMS in place, unintended pregnancies persist.

📍 Refresh your clinical skills with this free, case-based CME module:
https://cmeo.me/BC-140

Mycophenolate-containing medications are potent immunosuppressants used to prevent organ transplant rejection and to treat (off label) some autoimmune disorders. Despite the well-documented fetal risks associated with mycophenolate, as outlined in the U.S. Food and Drug Administration’s...

03/19/2026

🧠 Bias—personal or systemic—can shape who gets biomarker testing.

Learn practical ways to recognize and reduce bias to support equitable NSCLC treatment decisions.
🔗 https://cmeo.me/BC-138

Lung cancer disproportionately affects many groups across the United States, including ethnic minorities and poor, rural, and military service individuals, with higher incidence and mortality rates. While there are many factors contributing to this observation, clinicians...

03/19/2026

🏥 Even with effective therapies, too many patients fall out of care after diagnosis.
This activity highlights practical, scalable solutions to reduce attrition across the viral hepatitis care continuum.
📺 https://cmeo.me/SN-275

This activity focuses on one of the most persistent challenges in global hepatitis management: ensuring that patients who test positive for hepatitis B (HBV), hepatitis C (HCV), or hepatitis D (HDV) are successfully connected to ongoing...